Icahn Issues Statement Regarding Amylin Pharmaceuticals
NEW YORK, April 25, 2012 /PRNewswire/ -- Carl C. Icahn today announced that his affiliates had voluntarily dismissed their lawsuit against Amylin Pharmaceuticals which had sought an extension of the deadline to nominate directors at the 2012 annual meeting of shareholders. Mr. Icahn released the following statement:
The decision to discontinue our lawsuit seeking to extend the director nomination deadline was the result of discussions I had with Daniel Bradbury , Amylin's chief executive officer, that we agreed would not be publicly disclosed.
Mr. Icahn reiterated that he continues to strongly believe that the company should be sold at this time.
SOURCE Carl C. Icahn
More by this Source
Carl C. Icahn Issues Open Letter To Transocean Shareholders
May 13, 2013, 14:15 ET
Carl C. Icahn Issues Open Letter To Transocean Shareholders
May 02, 2013, 16:02 ET
Carl C. Icahn Issues Open Letter To Transocean Shareholders
Apr 30, 2013, 08:42 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.